PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
19-Jan-2022 PTC Therapeutics Announces Launch of 8th Annual STRIVE™ Awards Program to Fund Initiatives Benefitting the Duchenne Muscular Dystrophy Community PTC Therapeutics
19-Jan-2022 Engitix Announces $54m Series A Financing and a Strategic Collaboration with Dompé Farmaceutici Using Exscalate’s AI Supercomputing Power to Advance its Drug Discovery Pipeline in Fibrosis and Cancer Engitix Ltd
19-Jan-2022 Lead times and costs drastically reduced by digital supply chain Faller Packaging
19-Jan-2022 Element further expands its Life Sciences testing business with additional pharmaceutical and biotech testing capabilities in North America and Europe Element Materials Technology
19-Jan-2022 Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin diseases Almirall
19-Jan-2022 Solvay awards €300k science prize to Professor Katalin Karikó Solvay
19-Jan-2022 AlzeCure gets late-breaking abstract on NeuroRestore ACD856 clinical data accepted to AD/PD 2022 conference AlzeCure
19-Jan-2022 Ori Biotech raises over USD 100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform Ori Biotech
19-Jan-2022 Abivax's phase 1/2 clinical study results of ABX196 in liver cancer to be presented on Jan. 21, at ASCO GI Cancers Symposium 2022 ABIVAX
19-Jan-2022 Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients w/COVID-19 Respiratory Failure who've Exhausted All Approved Therapies RELIEF THERAPEUTICS Holding AG
18-Jan-2022 The Scottish Medicines Consortium accepts the use of Adtralza®▼(tralokinumab) for adult patients with moderate-to-severe atopic dermatitis who are candidates for systemic therapy Scottish Medicines Consortium (SMC)
18-Jan-2022 Egetis concludes that demonstrating treatment effects on T3 levels in MCT8-deficiency could provide a basis for marketing approval for Emcitate® in the US Egetis Therapeutics AB
18-Jan-2022 Orgenesis and Johns Hopkins University expand POCare in Maryland through creation of the Maryland Center for Cell Therapy Manufacturing Orgenesis
18-Jan-2022 Original-Research: Haemato AG (von First Berlin Equity Research GmbH) Haemato AG
18-Jan-2022 PTC Therapeutics Announces Launch of 8th Annual STRIVE™ Awards Program to Fund Initiatives Benefitting the Duchenne Muscular Dystrophy Community PTC Therapeutics
18-Jan-2022 CSL Behring AG publishes Offer Prospectus on public tender offer for all publicly held shares of Vifor Pharma Ltd. CSL Behring
18-Jan-2022 SMC ACCEPTS TAGRISSO® (osimertinib) FOR USE IN SCOTLAND FOR TREATMENT OF EGFR MUTATED ADVANCED LUNG CANCER AstraZeneca
18-Jan-2022 Neurimmune expands drug discovery collaboration with Ono Pharmaceutical in the field of neurodegenerative diseases Neurimmune AG
18-Jan-2022 Cheshire-based life sciences startup Cryoniss secures £500,000 investment from NPIF Maven Equity Finance Cryoniss Limited
18-Jan-2022 Trading update and outlook for 2022 Destiny Pharma plc